FIELD: biotechnology.
SUBSTANCE: method for the purification of full capsids of an adeno-associated virus (hereinafter – AAV) from a concentrated AAV fraction containing empty AAV capsids and full AAV capsids provides for: (i) loading to a zonal rotor of a) the concentrated AAV fraction and b) at least two sugar solutions, each of which is characterized by different sugar concentration, and each of which contains sugar at a concentration equivalent to sucrose concentration in the range from about 45% (in mass terms) to about 65% (in mass terms) of sucrose, (ii) operation of an ultracentrifuge containing a zonal rotor in a periodic mode, after which sugar gradient is formed, (iii) production of a sugar gradient fraction for the production of AAV fraction, wherein at least or about 60% of AAV particles in AAV fraction are full AAV capsids, wherein the total volume of sugar solutions and the concentrated AAV fraction is less than or equal to the volume of the zonal rotor, and a ratio of the volume of sugar solutions to the volume of the concentrated AAV fraction is less than or equal to one.
EFFECT: method allows for obtaining a high-purity effective product suitable for clinical use.
64 cl, 22 dwg, 19 tbl, 16 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS FOR PURIFICATION OF ADENO-ASSOCIATED VIRUSES | 2018 |
|
RU2785661C2 |
FORMULATIONS WITH ADENO-ASSOCIATED VIRUS | 2017 |
|
RU2769196C2 |
METHODS FOR DETERMINATION OF ACTIVITY OF ADENO-ASSOCIATED VIRAL PREPARATIONS | 2018 |
|
RU2785961C2 |
COMPLETELY SCALABLE METHOD FOR PRODUCING rAAV BASED ON COLUMNS | 2017 |
|
RU2754467C2 |
AGENTS AND METHOD OF PRODUCING VIRAL VECTORS AND VERSIONS OF THEIR USE | 2018 |
|
RU2818529C2 |
COMPOSITIONS AND METHODS OF TREATING MPS1 | 2014 |
|
RU2708318C2 |
GENE THERAPY OF OPHTHALMIC DISORDERS | 2016 |
|
RU2762747C2 |
METHOD OF VIRUS TREATMENT BY ULTRACENTRIFUGATION IN SUGAR CONCENTRATION GRADIENT (VERSIONS) | 2008 |
|
RU2503719C2 |
SCALABLE METHODS FOR OBTAINING RECOMBINANT VECTOR BASED ON ADENO-ASSOCIATED VIRUS (AAV) IN SYSTEM OF SERUM-FREE SUSPENSION CELL CULTURE, SUITABLE FOR CLINICAL USE | 2016 |
|
RU2766583C2 |
IMPROVED METHODS OF PURIFYING VECTORS BASED ON RECOMBINANT AAV | 2010 |
|
RU2588387C2 |
Authors
Dates
2022-06-03—Published
2017-11-03—Filed